Author:
Boeckx N,Jansen M W J C,Haskovec C,Vandenberghe P,van der Velden V H J,van Dongen J J M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference10 articles.
1. van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Sagli G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901–1928.
2. Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410–2414.
3. Haskovec C, Ponzetto C, Polak J, Maritano D, Zemanova Z, Serra A et al. P230 BCR/ABL protein may be associated with an acute leukaemia phenotype. Br J Haematol 1998; 103: 1104–1108.
4. Wada H, Mizutani S, Nishimura J, Usuki Y, Kohsaki M, Komai M et al. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. Cancer Res 1995; 55: 3192–3195.
5. Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero I et al. Disruption of the BCL11B gene through inv14(q11.2;q32.31) results in expression of BCL11B–TCRD fusion transcripts and is associated with absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005; 19: 201–208.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献